Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001213900-22-024317

10% owner sold 5,374 shares at $12.25 ($65,832)

From the SEC's structured data for this filing

Trades in this filing

Vivo Capital IX, LLC · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-05 Sale : show line 1 in the form −5,374 $12.25 $65,832 2,469,001 I
Open-market sales · 5,374 sh · avg $12.25 · $65,832
Loading xslF345X03/ownership.xml…